Key result
TAVR achieves 100% procedural success with hemodynamic improvement in high-risk rheumatic aortic stenosis.
Why the study?
The feasibility and outcomes of transcatheter aortic valve replacement in patients with severe rheumatic aortic stenosis were not well established.
Does transcatheter aortic valve replacement improve hemodynamics and symptoms in high-risk patients with severe rheumatic aortic stenosis?
Case Report (n=7)
Does transcatheter aortic valve replacement improve hemodynamics and symptoms in high-risk patients with severe rheumatic aortic stenosis?
TAVR appears feasible and results in favorable hemodynamic and symptomatic improvement in selected high-risk patients with severe rheumatic aortic stenosis.
Answers are grounded in this paper and cite their sources.
TAVR may be feasible in selected rheumatic AS cases; hypothesis-generating and requires larger prospective studies before practice change.
Transcatheter aortic valve replacement was performed in seven high-risk patients with severe rheumatic aortic stenosis, including four with prior mitral valve replacement. All procedures were successful with favourable hemodynamic and symptomatic improvement. Transcatheter aortic valve replacement (TAVR) appears feasible in selected rheumatic anatomies, supporting its expanding role in multivalvular rheumatic heart disease.
No takes yet. Share an insight, caveat, or question.
kumar et al. (2026) conducted a case report in Severe rheumatic aortic stenosis (n=7). Transcatheter aortic valve replacement (TAVR) was evaluated on Procedural success with hemodynamic and symptomatic improvement. Transcatheter aortic valve replacement achieved 100% procedural success with favorable hemodynamic and symptomatic improvement in 7 high-risk patients with severe rheumatic aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: